Blood group substances as potential therapeutic agents for the prevention and treatment of infection with noroviruses proving novel binding patterns in human tissues

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Yazawa, Shin ^a,b   Yokobori, Takehiko ^a   Ueta, Gen ^c   Ide, Munenori ^a   Altan, Bolag ^a   Thongprachum, Aksara ^d,e   Nishimura, Toyo ^b   Nakajima, Tamiko ^a   Kominato, Yoshihiko ^a   Asao, Takayuki ^a   Saniabadi, Abby R ^f   Furukawa, Kiyoshi ^c   Kuwano, Hiroyuki ^a   Pendu, Jacques Le ^g   Ushijima, Hiroshi ^d,e  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c NAGAOKA UNIVERSITY OF TECHNOLOGY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^g UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; INFECTION SENSITIVITY; JEJUNUM MUCOSA; NONHUMAN; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; SALIVA ANALYSIS; STOMACH MUCOSA; VIRUS ATTACHMENT; VIRUS LIKE AGENT;

ANIMALS; BLOOD GROUP ANTIGENS; CALICIVIRIDAE INFECTIONS; DECAPODIFORMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; NOROVIRUS; POLYSACCHARIDES; PROTEIN BINDING; SALIVA; SWINE; VIRION;

EID: 84895792677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089071     Document Type: Article

References (80)

1. Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, et al. (1972) Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med 140:578-583.
2. Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI (1999) Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis 179: 1334-1344. (Pubitemid 29246580)
3. Inouye S, Yamashita K, Yamadera S, Yoshikawa M, Kato N, et al. (2000) Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents. J Infect Dis 181: S270-274. (Pubitemid 30395078)
4. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, et al. (2004) Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363:682-688. (Pubitemid 38296554)
5. Hutson AM, Atmar RL, Estes MK (2004) Norovirus disease: changing epidemiology and host susceptibility factors. Trends in Microbiol 12:279-287. (Pubitemid 38686376)
6. Okada M, Ogawa T, Kaiho I, Shinozaki K (2005) Genetic analysis of noroviruses in Chiba prefecture, Japan, between 1999 and 2004. J Clin Microbiol 43:4391-4401. (Pubitemid 41298218)
7. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, et al. (1972) Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol 10:1075-1081.
8. Le Pendu J, Ruvoën-Clouet N, Kindberg E, Svensson L (2006) Mendelian resistance to human norovirus infections. Seminars in Immunol 18:375-386.
9. Glass RI, Parashar UD, Estes MK (2009) Norovirus gastroenteritis. N Engl Med 361: 1776-1785.
10. Jiang XI, Wang M, Graham DY, Estes MK (1992) Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Viol 66:6527-6532.
11. Hutson AM, Atmar RL, Graham DY, Estes MK (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185:1335-1337. (Pubitemid 34439142)
12. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, et al. (2003) Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548-553. (Pubitemid 36597100)
13. Hutson AM, Airaud F, Le Pendu J, Estes MK, Atmar RL (2005) Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol 77:116-120. (Pubitemid 41076487)
14. Frenck R, Bernstein DI, Xia M, Huang P, Zhong W, et al. (2012). Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis 206:1386-1393.
15. Marionneau S, Ruvoën N, Le Moullac-Vaidye B, Clement M, Cailleau-Thomas A, et al. (2002) Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterol 122:1967-1977.
16. Marionneau S, Airaud F, Bovin NV, Le Pendu J, Ruvoën-Clouet N (2005) Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J Infect Dis 192:1071-1077. (Pubitemid 41266806)
17. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS (2002) Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343. (Pubitemid 35304332)
18. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoën-Clouet N, et al. (2003) Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31. (Pubitemid 36829738)
19. Huang P, Farkas T, Zhong W, Tan M, Thornton S, et al. (2005) Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79:6714-6722. (Pubitemid 40677302)
20. Cheetham S, Souza M, McGregor R, Meulia T, Wang Q, et al. (2007) Binding patterns of human norovirus-like particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression. J Virol 81:3535-3544. (Pubitemid 46456662)
21. Tian P, Jiang X, Zhong W, Jensen HM, Brandl M, et al. (2007) Binding of recombinant norovirus like particle to histo-blood group antigen on cells in the lumen of pig duodenum. Res Vet Sci 83:410-418. (Pubitemid 47386975)
22. Tan M, Jin M, Xie H, Duan Z, Jiang X, et al. (2008) Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 80:1296-1301. (Pubitemid 351706011)
23. Bok K, Abente EJ, Realpe-Quintero M, Mitra T, Sosnovtsev SV, et al. (2009) Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol 83:11890-11901.
24. Levy AG, Widerlite L, Schwartz CJ, Dolin R, Blacklow NR, et al. (1976) Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterol 70:321-325.
25. Teunis PFM, Moe CL, Liu P, Miller SE, Lindesmith L, et al. (2008) Norwalk virus: how infectious is it? J. Med Virol 80:1468-1476. (Pubitemid 351897421)
26. Tan M, Jiang X (2010) Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathogens 6:e1000983. doi:10/1371/journal.ppat.1000983.
27. Estes MS, Atmar RL (2003) Viral pathogens of the intestine. In: Hecht GA (ed). Microbial Pathogenesis and the Intestinal Epithelial Cell. Washington DC. ASM Press, pp525-545.
28. Schreiber DS, Blacklow NR, Trier JS (1973) The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med 288:1318-1323.
29. Chan MD, Ho W, Sung JJ (2011) In vitro whole-virus binding of a norovirus genogroup II genotype 4 strain to cells of the lamina propria and Brunner's glands in the human duodenum. J Virol 85:8427-8430.
30. Yazawa S, Kominato Y, Ushijima H (2008) Protection against norovirus infection or removal of norovirus by using substance associated with blood type. WO 2010/010948 A1. PCT/JP2009/063273.
31. Yazawa S, Furukawa K, Kochibe N (1984) Isolation of fucosyl glycoproteins from human erythrocyte membranes by affinity chromatography using Aleuria aurantia lectin. J Biochem 96:1737-1742. (Pubitemid 15193104)
32. Iseki S, Okada S (1951) On a specific enzyme which decomposes group A substance. Proc Japan Acad 27:455-458.
33. Iseki S, Ikeda T (1956) On bacterial enzyme specifically decomposing group B substance. Proc Japan Acad 32:201-205.
34. Yazawa S, Furukawa K (1983) Immunochemical properties of human plasma α1-2fucosyltransferase specified by blood group H-gene. J Immunogenet 10:349-360. (Pubitemid 14243612)
35. Yazawa S, Akamatsu S, Tachikawa T, Naito H, Nakamura J, et al. (1993) Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res 84: 641-648. (Pubitemid 23222189)
36. Yazawa S, Nishimura T, Ide M, Asao T, Okamura A, et al. (2002) Tumor-related expression of a1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for α1,2fucosyltransferease. Glycobiology 12:545-553.
37. Tsuboi K, Asao T, Ide M, Hashimoto S, Noguchi K, et al. (2007) α1,2Fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues. Anal Surg Oncol 14:1880-1889. (Pubitemid 46870941)
38. Ruvoën-Clouet N, Mas E, Marionneau S, Guillon P, Lombardo D, et al. (2006) Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem J 393:627-634.
39. Shiota T, Okame M, Takanashi S, Khamrin P, Takagi M, et al. (2007) Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol 81:12298-12306. (Pubitemid 350085844)
40. Okame M, Shiota T, Hansman G, Takagi M, Yagyu F, et al. (2007) Antinorovirus polyclonal antibody and its potential for development of an antigen-ELISA. J Med Virol 79:1180-1186. (Pubitemid 47015419)
41. Kawamoto T (2003) Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants. Arch Histol Cytol 66:123-143.
42. Yazawa S, Nishihara S, Iwasaki H, Asao T, Nagamachi Y, et al. (1995) Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res 55:1473-1478.
43. Bendich A, Kabat EA, Bezer AE (1946) Immunochemical studies on blood groups. III. Properties of purified blood group A substances from individual hog stomach lining. J Exp Med 83:485-497.
44. Morgan WTJ, King HK (1943) Studies in immunochemistry. 7. The isolation from hog gastric mucin of the polysaccharide blood group A specificity. Biochem J 37:640-651.
45. Yazawa S, Kochibe N, Asao T (1990) A simple procedure for isolation of tumor-associated antigens by affinity chromatography using fucose-specific Aleuria aurantia lectin. Immunol Invest 19:319-327. (Pubitemid 20305599)
46. Watkins WM (1995) Biosynthesis 5. Molecular basis of antigenic specificity in the ABO, H and Lewis blood-group systems. In Mountreuil J, Vliegenthart JFG, Schachter H (ed), Glycoproteins. Elsevier Science, Amsterdam, The Netherlands. pp313-390.
47. Schenkel-Brunner H (1995) Chemical and biochemical basis of antigen specificity. In Human Blood Groups. Springer-Verlag, New York.
48. Thomsson KA, Schulz BL, Packer NH, Karlsson NG (2005) MUC5B glycosylation in human saliva reflects blood group and secretor status. Glycobiology 15:791-804. (Pubitemid 41417982)
49. Issa S, Moran AP, Ustinov SN, Lin JH, Ligtenberg AJ, et al. (2010) O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology 20:1046-1057.
50. Horowitz MI (1977) Gastrointestinal glycoproteinsp. In Horowitz MI, Pigman W (ed), The Glycoconjugates, vol. 1. Academic Press, New York. pp189-257.
51. Daniels G (1995) ABO, Hh, and Lewis Blood Group System, In Human Blood Groups. Blackwell Science, London, UK. pp8-120.
52. b) and type 2 (X, Y, H) blood group-related antigens in the human pyloric and duodenal mucosae. Lab Invest 53:219-227.
53. Green FR, Greenwell P, Dickson L, Griffiths B, Noades J, et al. (1988) Expression of the ABH, Lewis, and related antigens on the glycoproteins of the human jejunal brush border. Subcellular Biochem 12:119-153.
54. Varki A, Cummings R, Esko J, Freeze H, Hart G, et al. (1999) Microbial carbohydrate binding proteins. In Essentials of Glycobiology. Cold Spring Harbor Lab. Press. New York. pp429-440.
55. Tan M, Jiang X (2011) Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol 19:382-388.
56. Tan M, Jiang X (2005) Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends in Microbiol 13:285-293. (Pubitemid 40779817)
57. Harrington PR, Vinjé J, Moe CL, Baric RS (2004) Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J Virol 78:3035-3045. (Pubitemid 38314361)
58. Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, et al. (2008) Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J Virol 82:10756-10767. (Pubitemid 352691181)
59. Tan M, Xia M, Cao S, Huang P, Farkas T, et al. (2008) Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379:324-334.
60. de Rougemont A, Ruvoen-Clouet N, Simon B, Simon B, Estienney M, et al. (2011) Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol 85:4057-4070.
61. Chen Y, Tan M, Xia M, Hao N, Zhang XC, et al. (2011) Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathogens 7:1-14.
62. Nasir W, Frank M, Koppisetty CAK, Larson G, Nyholm P (2012) Lewis histo-blood group α1,3/α1,4 fucose residues may both mediate binding to GII.4 noroviruses. Glycobiology 22:1163-1172.
63. Kubota T, Kumagai A, Ito H, Furukawa S, Someya Y, et al. (2012) Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol 86:11138-11150.
64. Asao T, Yazawa S, Nishimura T, Hayashi T, Shimaoka H, et al. (2013) Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma a1-acid glycoprotein. BioMed Research Int. http://dx.doi.org/10.1155/ 2013/834790.
65. Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB (1995) Sequence and expression of a candidate for the human Secretor blood group α (1,2)fucosyltransferase gene (FUT2). J Biol Chem 270:4640-4649.
66. Yazawa S, Kishi K, Akamatsu S, Oh-kawara H, Seno T, et al. (1996) A search for the Secretor gene nonsense mutation (G428 to A428) in Japanese nonsecretors. Transfusion 31:286.
67. Kudo T, Iwasaki H, Nishihara S, Shinya N, Ando T, et al. (1996) Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 271:9830-9837.
68. Koda Y, Soejima M, Liu Y, Kimura H (1996) Molecular basis for secretor type α (1,2)- fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am J Hum Genet 59:343-350. (Pubitemid 26266349)
69. Bendich A, Kabat EA, Bezer AE (1947) Immunochemical studies on blood groups. V. Further characterization of blood group A and O substances from individual hog stomachs. J Am Chem Soc 69:2163-2167.
70. Chadwick EW, Smith H, Annison EA, Morgan WTJ (1949) Serologic character of hog gastric mucin. Nature 164:61.
71. Iseki S (1977) ABH blood group substances in living organisms. In Mohn JF, Plunkett RW, Cunningham RK, Lambert RM (eds), Human Blood Groups. Karger, Basel, Switzerland. pp126-133.
72. Slomiany BL, Slomiany A (1978) Blood-group-(A+H) complex fucolipids of hog gastric mucosa. Eur J Biochem 90:39-49. (Pubitemid 9013124)
73. Tian P, Brandl M, Mandrell R (2005) Porcine gastric mucin binds to recombinant norovirus particles and competitively inhibits their binding to histo-blood group antigens and Caco-2 cells. Lett Applied Microbiol 41:315-320. (Pubitemid 41392471)
74. Huang P, Morrow AL, Jiang X (2009) The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition. Glycoconj J 26:1085-1096.
75. Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero L, et al. (2004) Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr 145:297-303. (Pubitemid 39165674)
76. Okame M, Akihara S, Hansman G, Hainian Y, Tran HT, et al. (2006) Existence of multiple genotypes associated with acute gastroenteritis during 6-year survey of norovirus infection in Japan. J Med Virol 78:1318-1324. (Pubitemid 44387518)
77. Phan TG, Kuroiwa T, Kaneshi K, Ueda Y, Nakaya S, et al. (2006) Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in Japan. J. Med Virol 78:971-978. (Pubitemid 43856707)
78. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, et al. (2007) Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol 81:9932-9941. (Pubitemid 350067696)
79. Zheng D, Widdowson M, Glass RI, Vinjé J (2010) Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol 48:168-177.
80. Yang Y, Xia M, Tan M, Huang P, Zhong W, et al. (2010) Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol 84: 9595-9607.